Activity predication of rhodomyrtus tomentosa (Aiton) hassk against ace1 inhibitors
DOI:
https://doi.org/10.35335/midwifery.v11i2.1271Keywords:
ACE, Tomentosa, TomentosinAbstract
ACE is a peptidyl-dipeptidase enzyme that catalyzes the conversion of substrates from angiotensin I to angiotensin II. These changes cause constriction of blood vessels so that blood pressure increases (hypertension), so This study aims to find compounds that have the potential to reduce blood pressure through the pathway of ACE1 enzyme inhibition. The method used is docking, the material used is a compound contained from Rhodomyrtus tomentosa and. The ACE1 protein was obtained from RCSB with the code 1UZF. The equipment used was an online pass webserver, PLNTS software and discovery studio. This research was started by redocking the native ligand to determine the coordinates and radius, followed by validating the docking results. The results of the early stage screening obtained 4 compounds with a threshold value above 0.3, these four compounds were continued with the docking test. The docking scores obtained were Afrormosin (-59.620); Pedunculagin (-45.205); Tomentosine (-70.986); Desgalloylstachyurin (-54.374). The conclusion obtained is that the Tomentosine compound binds most easily to ACE1
Downloads
References
Abd Hamid, H., Mutazah, R., Yusoff, M. M., Abd Karim, N. A., & Abdull Razis, A. F. (2017). Comparative analysis of antioxidant and antiproliferative activities of Rhodomyrtus tomentosa extracts prepared with various solvents. Food and Chemical Toxicology, 108, 451–457. https://doi.org/https://doi.org/10.1016/j.fct.2016.10.004
ChemAxon. (2016). ChemAxon - Software Solutions and Services for Chemistry and Biology. In MarvinSketch, Version 16.10.31. https://chemaxon.com/
de Araújo Lopes, A., Magalhães, T. R., de Andrade Uchôa, D. E., Silveira, E. R., Azzolini, A. E. C. S., Kabeya, L. M., Lucisano-Valim, Y. M., Vasconcelos, S. M. M., de Barros Viana, G. S., & Leal, L. K. A. M. (2013). Afrormosin, an Isoflavonoid from Amburana cearensis A. C. Smith, Modulates the Inflammatory Response of Stimulated Human Neutrophils. Basic & Clinical Pharmacology & Toxicology, 113(6), 363–369. https://doi.org/10.1111/bcpt.12106
Ghasemi, S., Koohi, D. E., Emmamzadehhashemi, M. S. B., Khamas, S. S., Moazen, M., Hashemi, A. K., Amin, G., Golfakhrabadi, F., Yousefi, Z., & Yousefbeyk, F. (2018). Investigation of phenolic compounds and antioxidant activity of leaves extracts from seventeen cultivars of Iranian olive (Olea europaea L.). Journal of Food Science and Technology, 55(11), 4600–4607. https://doi.org/10.1007/s13197-018-3398-1
Idris, M., Sukandar, E. R., Purnomo, A. S., Martak, F., & Fatmawati, S. (2022). Antidiabetic, cytotoxic and antioxidant activities of Rhodomyrtus tomentosa leaf extracts. RSC Advances, 12(39), 25697–25710. https://doi.org/10.1039/D2RA03944C
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith, S. C. J., Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T. J., Narva, A. S., & Ortiz, E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5), 507–520. https://doi.org/10.1001/jama.2013.284427
Joseph, J., Karthika, T., Das, V. R. A., & Raj, V. S. (2022). The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction. Current Pharmaceutical Biotechnology, 23(8), 1118–1129. https://doi.org/10.2174/1389201022666210810111716
Khirzin, H., Sukarno, S., Yuliana, N., Fawzya, Y., & Chasanah, E. (2015). The Activity of Angiotensin Converting Enzyme (ACE) Inhibitor and Collagen Peptide Antioxidant from Gama Sea Cucumber (Stichopus variegatus). Jurnal Pascapanen Dan Bioteknologi Kelautan Dan Perikanan, 10, 27–35. https://doi.org/10.15578/jpbkp.v10i1.242
Kim, H., Han, M., Shin, S.-A., An, J., Ahn, M.-J., Lee, J. H., Park, H. H., & Lee, C. S. (2022). Afrormosin exerts an anticancer effect via MAPK and AKT signaling pathways in B16F10 cells. Applied Biological Chemistry, 65(1), 71. https://doi.org/10.1186/s13765-022-00743-5
Korb, O., Stützle, T., & Exner, T. E. (2009). Empirical scoring functions for advanced Protein-Ligand docking with PLANTS. Journal of Chemical Information and Modeling, 49(1), 84–96. https://doi.org/10.1021/ci800298z
Korzeniowska, K., Cielewiczi, A., Pawlaczyk, M., Motowidlo, K., Andrys-Wawrzyniak, I., & Jablecka, A. (2017). ANGIOEDEMA AFTER ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. Acta Poloniae Pharmaceutica, 74(3), 983–986.
Krieger, E., & Vriend, G. (2014). YASARA Viewâ€â€Âmolecular graphics for all devicesâ€â€Âfrom smartphones to workstations. Bioinformatics, 30(20), 2981–2982. https://doi.org/10.1093/bioinformatics/btu426
Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000). PASS: prediction of activity spectra for biologically active substances. Bioinformatics (Oxford, England), 16(8), 747–748. https://doi.org/10.1093/bioinformatics/16.8.747
Larson, A. J., Symons, J. D., & Jalili, T. (2012). Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Advances in Nutrition (Bethesda, Md.), 3(1), 39–46. https://doi.org/10.3945/an.111.001271
Messerli, F. H., Bangalore, S., Bavishi, C., & Rimoldi, S. F. (2018). Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? Journal of the American College of Cardiology, 71(13), 1474–1482. https://doi.org/10.1016/j.jacc.2018.01.058
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E. J., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., Granger, C. B., Krumholz, H. M., Linderbaum, J. A., Morrow, D. A., Newby, L. K., Ornato, J. P., Ou, N., Radford, M. J., Tamis-Holland, J. E., … Yancy, C. W. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 127(4), e362-425. https://doi.org/10.1161/CIR.0b013e3182742cf6
Page, M. R. (2014). The JNC 8 hypertension guidelines: an in-depth guide. In The American journal of managed care (Vol. 20, Issue 1 Spec No., p. E8).
Pongpanich, P., Pitakpaiboonkul, P., Takkavatakarn, K., Praditpornsilpa, K., Eiam-Ong, S., & Susantitaphong, P. (2018). The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis. International Urology and Nephrology, 50(12), 2261–2278. https://doi.org/10.1007/s11255-018-1991-x
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., … van der Meer, P. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution o. European Heart Journal, 37(27), 2129–2200. https://doi.org/10.1093/eurheartj/ehw128
Riyadi, P. (2018). Peptida Bioaktif Untuk Penurunan Tekanan Darah Dari Hidrolisa Limbah Perikanan : Kajian Pustaka Bioactive Peptide For Lowering Pressure Blood From Fisheris By-Product : A Review. Jurnal Pengolahan Dan Bioteknologi Hasil Perikanan, 7(1), 1–6.
Rosano, G. M. C., Tamargo, J., Kjeldsen, K. P., Lainscak, M., Agewall, S., Anker, S. D., Ceconi, C., Coats, A. J. S., Drexel, H., Filippatos, G., Kaski, J. C., Lund, L., Niessner, A., Ponikowski, P., Savarese, G., Schmidt, T. A., Seferovic, P., Wassmann, S., Walther, T., & Lewis, B. S. (2018). Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society . European Heart Journal. Cardiovascular Pharmacotherapy, 4(3), 180–188. https://doi.org/10.1093/ehjcvp/pvy015
Sang, V. T., & Ngo, D.-H. (2019). The Health Beneficial Properties of Rhodomyrtus tomentosa as Potential Functional Food. Biomolecules, 9, 76. https://doi.org/10.3390/biom9020076
Silvariño, R., Rios, P., Baldovinos, G., Chichet, M. A., Perg, N., Sola, L., Saona, G., De Souza, N., Lamadrid, V., & Gadola, L. (2019). Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used? Nephron, 143(2), 100–107. https://doi.org/10.1159/000500925
Sorodoc, V., Sorodoc, L., Lionte, C., Gazzi, E., Jaba, I. M., & Mungiu, O. C. (2010). [Intentional poisoning with ACE inhibitors. Emergeny Hospital Iaşi]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 114(2), 359–362.
Sugamoto, K., Tanaka, Y. L., Saito, A., Goto, Y., Nakayama, T., Okabayashi, T., Kunitake, H., & Morishita, K. (2022). Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes. Biochemical and Biophysical Research Communications, 615, 56–62. https://doi.org/10.1016/j.bbrc.2022.04.072
Systèmes, D. (2020). Free Download: BIOVIA Discovery Studio Visualizer - Dassault Systèmes. https://discover.3ds.com/discovery-studio-visualizer-download#_ga=2.4935860.685747970.1587999055-a5d1c1c0-3176-11e9-a86f-e302515d21c8
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E. J., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C. J., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A. S., … Wright, J. T. J. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P. Journal of the American College of Cardiology, 71(19), e127–e248. https://doi.org/10.1016/j.jacc.2017.11.006
Widiasari, S. (2018). Mekanisme Inhibisi Angiotensin Converting Enzym Oleh Flavonoid Pada Hipertensi Inhibition Angiotensin Converting Enzym Mechanism By Flavonoid in Hypertension. Collaborative Medical Journal, 1(2), 30–44. https://doi.org/http://jurnal.univrab.ac.id/index.php/cmj/article/view/474
Williams, B. (2016). Drug discovery in renin-angiotensin system intervention: past and future. Therapeutic Advances in Cardiovascular Disease, 10(3), 118–125. https://doi.org/10.1177/1753944716642680
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., Kahan, T., Mahfoud, F., Redon, J., Ruilope, L., Zanchetti, A., Kerins, M., Kjeldsen, S. E., Kreutz, R., Laurent, S., … Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104. https://doi.org/10.1093/eurheartj/ehy339
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E. J., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., Hollenberg, S. M., Lindenfeld, J., Masoudi, F. A., McBride, P. E., Peterson, P. N., Stevenson, L. W., & Westlake, C. (2017). 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Ame. Circulation, 136(6), e137–e161. https://doi.org/10.1161/CIR.0000000000000509
Zhang, Y., Ding, X., Hua, B., Liu, Q., Chen, H., Zhao, X.-Q., Li, W., & Li, H. (2020). Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome. Journal of Translational Medicine, 18(1), 150. https://doi.org/10.1186/s12967-020-02314-y
